ROCO
4107
Market cap252mUSD
Jul 09, Last price
117.00TWD
1D
0.00%
1Q
-4.49%
Jan 2017
-1.68%
IPO
324.68%
Name
Bioteque Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Taipei, Taiwan, in 1991, Bioteque Corporation operates as a global manufacturer and supplier of medical devices, serving markets across Asia, South America, North America, and other international regions. The company specializes in a diverse range of medical disposables, critical for applications such as hemodialysis access and endovascular treatments. Its comprehensive product line features dialysis equipment, including bloodlines, A.V.F. needles, and hemodialysis catheters; interventional radiology solutions like pigtail drainage catheter sets and introducer sets; and urology essentials such as ureteral stent sets and urine collection bags. Furthermore, Bioteque offers IV administration products, including PVC infusion bags and twist-off ports; respiratory care items like closed suction catheters and endotracheal tubes; and a suite of vascular access products, including angiographic catheters, PTA balloon dilatation catheters, and guidewires. The company also manufactures a wide array of specialized medical components, such as dialyzer connectors, various luer lock connectors, filters, clamps, and transducer protectors, alongside medical masks.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||